Recombinant human growth hormone treatment of children following renal transplantation
- 1 January 1991
- journal article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 5 (1) , 147-151
- https://doi.org/10.1007/bf00852873
Abstract
Nine growth-retarded renal allograft recipients received either thrice weekly or daily subcutaneous recombinant human growth hormone (rhGH) for 6–30 months. The annualized growth velocity for the initial year of rhGH treatment was significantly greater than that of the preceding year (2.5±2.1 vs 5.7±2.7;PPP<0.002) following rhGH treatment compared with baseline values. These preliminary data indicate that rhGH treatment may be effective in improving the growth velocity of growth-retarded renal allograft recipients.Keywords
This publication has 6 references indexed in Scilit:
- Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failureThe Journal of Pediatrics, 1989
- Improvement of growth and food utilization by human recombinant growth hormone in uremiaKidney International, 1987
- Serum Concentrations of Insulin-Like Growth Factor (IGF)-1, IGF-2 and Unsaturated Somatomedin Carrier Proteins in Children With Chronic Renal FailureAmerican Journal of Kidney Diseases, 1987
- Growth and sexual maturation in children after kidney transplantationThe Journal of Pediatrics, 1987
- Comparison of CAPD and Hemodialysis in ChildrenPublished by Springer Nature ,1987
- Growth assessment in abnormal childrenKidney International, 1978